{"abstract":"The Food and Drug Administration (FDA) is announcing theavailability of a small entity compliance guide (SECG) for a final rule published in the Federal Register of February 11, 2004 (69 FR 6788), entitled \"Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk.\" This SECG is intended to set forth in plain language the requirements of the regulation and to help small businesses understand the regulation.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2008/07/17/E8-16396.html","cfr_references":[],"citation":"73 FR 41089","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Submit written or electronic comments on the SECG at any time.","disposition_notes":null,"docket_ids":["Docket No. FDA-1995-N-0054"],"dockets":[],"document_number":"E8-16396","effective_on":null,"end_page":41090,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2008/07/17/E8-16396.xml","html_url":"https://www.federalregister.gov/documents/2008/07/17/E8-16396/small-entity-compliance-guide-final-rule-declaring-dietary-supplements-containing-ephedrine","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/E8-16396?publication_date=2008-07-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2008-07-17/E8-16396/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":411,"last_updated":"2026-04-14 16:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2008-07-17/pdf/E8-16396.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2008-07-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2008/07/17/E8-16396.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2011-11-14T12:51:53Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":41089,"subtype":null,"title":"Small Entity Compliance Guide: Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Availability","toc_doc":"Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk","toc_subject":"Small Entity Compliance Guide; Availability:","topics":[],"type":"Notice","volume":73}